Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics said today it has closed a previously announced $13.7 million underwritten public offering.

Though the firm had aimed to raise net proceeds of $12.7 million, it said today total net proceeds were $12.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.